Work

Combating Atherosclerosis With LXR And PPAR Agonists: Is Rational Multitargeted Polypharmacy the Future of Therapeutics in Complex Diseases?

Year: 2004

Type: article

Source: Molecular Interventions

DOI: 10.1124/mi.4.5.5

Author: T. Kino

Institutions: National Institutes of Health, Eunice Kennedy Shriver National Institute of Child Health and Human Development

Language: English

Topic: Peroxisome Proliferator-Activated Receptors

Subfield: Molecular Biology

Field: Biochemistry, Genetics and Molecular Biology

Domain: Life Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W2085093438

FWCI: 0.355

Cites:

Cited by: 3

Related to: 10